Acceleration of BRAFV600E-induced thyroid carcinogenesis by TGFβ signal deficiency in mice.
Mika ShimamuraTomomi KurashigeRassul KuatovMasahiro NakashimaYuji NagayamaPublished in: Endocrine (2020)
In a mouse model, defective TGFβ signaling pathway accelerates BRAFV600E-induced thyroid cancer development, which is occasionally accompanied by reduced TG expression implying dedifferentiation. The former finding is consistent with anti-tumorigenic ability of TGFβ in early tumorigenic process, but the latter is contradictory to generally accepted concept for TGFβ-induction of dedifferentiation.